101 related articles for article (PubMed ID: 8827877)
1. [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
Doi T; Sakamaki S; Koike K; Matsunaga T; Kobayashi D; Muramatsu H; Sato T; Watanabe N; Kougo Y; Niitsu Y
Rinsho Ketsueki; 1996 Aug; 37(8):676-81. PubMed ID: 8827877
[TBL] [Abstract][Full Text] [Related]
2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
3. [Smoldering leukemia with CD7.CD34(+), immunoglobulin heavy chain rearrangement (+) and hypoplastic marrow with myelofibrosis].
Hara T; Tsurumi H; Yamada T; Sawada M; Naito T; Murakami N; Moriwaki H; Muto Y
Rinsho Ketsueki; 1997 Jan; 38(1):21-7. PubMed ID: 9028157
[TBL] [Abstract][Full Text] [Related]
4. CD7 positive acute lymphoblastic leukemia successfully treated with high dose cytosine arabinoside and mitoxantrone: a case report.
Nakajima H; Kizaki M; Kawai Y; Ishida A; Tokuhira M; Watanabe K; Ikeda Y
Keio J Med; 1996 Jun; 45(2):114-7. PubMed ID: 8683901
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
Marinov J; Koubek K; StarĂ½ J
Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Bradstock K; Matthews J; Benson E; Page F; Bishop J
Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
8. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization.
Kirk JA; Reems JA; Roecklein BA; Van Devanter DR; Bryant EM; Radich J; Edmands S; Lee A; Torok-Storb B
Blood; 1995 Jul; 86(2):737-43. PubMed ID: 7541674
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
10. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.
Kimura N; Akiyoshi T; Uchida T; Okamura J; Kozuru M; Nishimura J; Ohyashiki JH; Kikuchi M; Niho Y; Okumura M
Leukemia; 1996 Apr; 10(4):650-7. PubMed ID: 8618442
[TBL] [Abstract][Full Text] [Related]
12. CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia.
Tasaka T; Nagai M; Murao S; Yamaguchi M; Kitanaka A; Sasaki K; Murata M; Tanaka T; Kuwabara H; Ikeda K
Am J Hematol; 1993 Sep; 44(1):53-7. PubMed ID: 7688180
[TBL] [Abstract][Full Text] [Related]
13. Skin infiltration in acute promyelocytic leukemia.
Nagao K; Kikuchi A; Kawai Y; Kizaki M; Ikeda Y; Nishikawa T
Dermatology; 1997; 194(2):168-71. PubMed ID: 9094468
[TBL] [Abstract][Full Text] [Related]
14. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
15. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
16. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
17. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
[TBL] [Abstract][Full Text] [Related]
18. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
20. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]